000 | 02700nam a22003257a 4500 | ||
---|---|---|---|
001 | A. 8359 | ||
003 | OSt | ||
005 | 20240305193421.0 | ||
008 | 220510b |||||||| |||| 00| 0 eng d | ||
020 | _a0387970304 | ||
020 | _a 9780387970301 | ||
040 | _cDLC | ||
082 | _a616.152 SHA | ||
100 |
_a Nasrollah T. Shahidi _937193 |
||
245 | _aAplastic Anemia and Other Bone Marrow Failure Syndromes | ||
250 | _aillustrated | ||
260 |
_aLondon _bSpringer New York, 1990 Original from the University of Michigan Digitized _c7 Aug 2008 |
||
300 | _a 236 pages | ||
520 | _aDuring the past decade, there have been numerous direct and indirect scientific contributions to both the etiology and therapy of aplastic anemia and related bone marrow failure syndromes. Clinical observations, such as autologous bone marrow recovery after conditioning with immunosup pressive agents for bone marrow transplantation; failure to achieve en graftment in some identical twins without prior immunosuppressive ther apy; and hematologic response to immunosuppressive agents, have led to the concept of immune-mediated etiology of acquired aplastic anemia. Such a concept was further strengthened by laboratory findings, implicat ing the role of activated cytotoxic T lymphocytes and abnormal produc tion of inhibitory lymphokines. The immunologic mechanisms may also apply to the idiosyncratic bone marrow aplasias associated with drugs, toxic chemicals, and viruses. These agents may alter normal cellular recog nition sites by interacting with cellular components and result in loss of self tolerance. Immunologic mechanisms have long been advocated in many other organ failures, and the hemopoietic organ is no exception. It is of interest that parallel clinical and laboratory investigations in juvenile diabetes mellitus type I and in rodent models of this disease have yielded results compatible with the same pathogenic mechanisms. The infiltration of pancreatic islets by activated T lymphocytes, functional and morphological alterations of islet cells upon incubation with lymphokines such as gamma interferon and tumor necrosis factor, and clinical response to cyclosporine are a few examples. | ||
600 |
_xScience / Life Sciences / Molecular Biology _927008 |
||
600 |
_x Science / Life Sciences / Cell Biology _927913 |
||
600 |
_xMedical / Pediatrics _926838 |
||
600 |
_x Medical / Oncology / General _926891 |
||
600 |
_xMedical / Oncology _929196 |
||
600 |
_x Medical / Immunology _926958 |
||
600 |
_x Medical / Hematology _927137 |
||
600 |
_x Medical / Clinical Medicine _926816 |
||
600 |
_xMedical › Oncology › General _926780 |
||
942 |
_2ddc _cBK |
||
999 |
_c17892 _d17892 |